Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
TAOX	TAO SYNERGIES INC	$28.77M	-134.10%	-109.50%	-83.05%	-152.70%	0.21	27.40	100.00%	-3,783.50%	-3,615.43%
DTIL	PRECISION BIOSCIENCES INC	$212.61M	-79.60%	-34.80%	-31.01%	-113.80%	0.89	14.02	100.00%	-96.70%	-93.67%
KPTI	KARYOPHARM THERAPEUTICS INC	$218.02M	N/A	-176.90%	-1,045.36%	-88.40%	-1.50	1.08	96.00%	-129.00%	-97.64%
ANL	ADLAI NORTYE LTD	$436.37M	-414.00%	-67.20%	472.51%	547.00%	-5.14	0.65	100.00%	-710.60%	-679.94%
AQST	AQUESTIVE THERAPEUTICS INC	$531.91M	N/A	-49.30%	-47.68%	-39.50%	-5.14	4.10	63.50%	-137.10%	-103.74%
ALEC	ALECTOR INC	$215.39M	-295.20%	-40.90%	-62.94%	-60.60%	22.11	5.25	100.00%	-680.80%	-679.92%
HCM	HUTCHMED (CHINA) LTD	$2.03B	45.70%	30.20%	36.41%	45.60%	0.41	4.96	38.70%	83.30%	95.42%
KYMR	KYMERA THERAPEUTICS INC	$9.44B	-25.00%	-22.30%	-19.59%	-26.80%	0.08	10.81	100.00%	-612.00%	-611.26%
PEN	PENUMBRA INC	$12.52B	12.30%	9.60%	12.03%	14.90%	0.29	6.02	67.40%	11.80%	13.96%
QTTB	Q32 BIO INC	$218.14M	230.70%	53.30%	62.72%	217.40%	0.38	5.36	100.00%	61.90%	61.86%
WRBY	WARBY PARKER INC	$3.59B	0.40%	0.20%	-1.05%	-1.20%	0.96	2.33	53.40%	0.20%	-0.69%
NTRA	NATERA INC	$40.64B	-15.10%	-10.50%	-13.72%	-48.50%	0.47	2.96	65.10%	-9.00%	-11.28%
BCRX	BIOCRYST PHARMACEUTICALS INC	$2.58B	N/A	-97.30%	-140.55%	-44.00%	-1.84	1.91	97.80%	-51.70%	-42.79%
PTCT	PTC THERAPEUTICS INC	$7.09B	N/A	-6.80%	-3.52%	-6.70%	-16.90	2.44	92.50%	-22.60%	-8.28%
KZIA	KAZIA THERAPEUTICS LTD	$741.37M	-217.80%	-51.20%	-52.23%	207.80%	0.53	2.87	100.00%	-1,200.90%	-1,285.72%
CERT	CERTARA INC	$1.11B	-1.40%	-1.00%	1.11%	5.00%	0.48	1.88	61.60%	-3.60%	3.57%
SNDX	SYNDAX PHARMACEUTICALS INC	$1.96B	-256.70%	-45.20%	-53.21%	-31.60%	10.36	5.47	96.00%	-111.90%	-94.59%
ABT	ABBOTT LABORATORIES	$166.57B	12.10%	6.90%	9.42%	17.00%	1.10	1.39	56.30%	13.90%	19.22%
SNWV	SANUWAVE HEALTH INC	$90.29M	-450.60%	44.90%	112.15%	150.60%	19.18	1.31	76.70%	36.20%	47.55%
GH	GUARDANT HEALTH INC	$22.39B	N/A	-26.50%	-26.49%	-21.00%	-11.58	4.68	64.90%	-40.10%	-39.80%
CRMD	CORMEDIX INC	$689.59M	50.40%	27.40%	27.34%	86.10%	0.87	2.98	85.80%	45.20%	46.94%
KARD	KARDIGAN INC	N/A	N/A	N/A	N/A	N/A	-0.17	9.42	N/A	N/A	N/A
BNR	BURNING ROCK BIOTECH LTD	$108.67M	-11.00%	-7.30%	-10.34%	-37.40%	0.53	3.05	74.60%	-11.50%	-11.22%
MDLN	MEDLINE INC	$56.16B	N/A	N/A	N/A	N/A	1.75	4.41	N/A	N/A	N/A
SI	SHOULDER INNOVATIONS INC	$443.59M	-51.30%	-30.10%	-30.27%	-38.10%	0.21	11.81	76.80%	-81.80%	-83.14%
INGN	INOGEN INC	$180.59M	-12.90%	-8.30%	-11.41%	-23.40%	0.56	3.10	44.30%	-7.10%	-7.28%
QURE	UNIQURE NV	$2.61B	-145.80%	-27.20%	-19.78%	-16.30%	4.21	10.40	90.60%	-1,154.40%	-786.66%
SY	SO-YOUNG INTERNATIONAL INC	$163.62M	-16.00%	-9.70%	-14.23%	-22.50%	0.71	1.73	46.00%	-15.60%	-15.47%
BDMD	BAIRD MEDICAL INVESTMENT HOLDINGS LTD	$46.72M	-76.80%	-36.90%	-67.96%	-43.30%	1.23	1.70	83.80%	-121.00%	-112.59%
CDXS	CODEXIS INC	$241.78M	-68.10%	-23.70%	-23.36%	-18.10%	1.99	5.36	88.90%	-41.00%	-34.26%
LEGN	LEGEND BIOTECH CORP	$5.21B	-24.90%	-14.90%	-19.75%	-31.30%	0.65	2.13	55.00%	-22.00%	-18.86%
BKD	BROOKDALE SENIOR LIVING INC	$3.72B	N/A	-3.40%	0.54%	0.30%	-106.42	1.03	20.30%	-6.50%	0.93%
NBTX	NANOBIOTIX SA	$1.99B	N/A	-35.50%	-85.10%	-27.90%	-1.80	1.09	100.00%	-73.50%	-26.77%
CV	CAPSOVISION INC	$330.26M	N/A	-136.00%	-130.93%	-582.90%	0.28	4.57	51.70%	-198.90%	-198.69%
CYTK	CYTOKINETICS INC	$10.65B	N/A	-61.90%	-72.46%	-35.50%	-2.54	4.21	97.60%	-784.00%	-735.60%
TRAX	FIRST TRACKS BIOTHERAPEUTICS INC	$699.24M	N/A	N/A	N/A	N/A	0.13	8.74	N/A	N/A	N/A
HYFT	MINDWALK HOLDINGS CORP	$76.61M	-63.70%	-36.50%	-67.58%	-72.80%	0.55	3.74	60.30%	-66.50%	-65.87%
PRVA	PRIVIA HEALTH GROUP INC	$3.43B	3.00%	1.60%	4.83%	-148.20%	0.81	1.61	10.00%	1.00%	1.76%
CPIX	CUMBERLAND PHARMACEUTICALS INC	$92.30M	-29.30%	-10.50%	-18.97%	-28.50%	2.30	0.95	82.90%	-17.60%	-16.52%
LGND	LIGAND PHARMACEUTICALS INC	$6.42B	16.20%	11.10%	12.77%	15.60%	0.54	21.28	95.30%	55.90%	69.40%
ASMB	ASSEMBLY BIOSCIENCES INC	$459.22M	-4.20%	-3.10%	-3.18%	-5.10%	0.19	6.65	N/A	N/A	N/A
CCCC	C4 THERAPEUTICS INC	$457.75M	-50.70%	-33.20%	-34.38%	-38.90%	0.40	9.01	100.00%	-297.80%	-297.41%
GMAB	GENMAB A	$17.99B	14.50%	8.50%	12.60%	34.20%	1.18	2.18	93.30%	21.00%	36.17%
MMED	MINIMED GROUP INC	$4.29B	-9.60%	-7.50%	-5.22%	-17.40%	0.28	1.92	54.20%	-10.70%	-6.61%
TWST	TWIST BIOSCIENCE CORP	$6.22B	-17.50%	-12.50%	-14.48%	-20.30%	0.49	2.70	52.10%	-19.80%	-19.67%
QUCY	QUANTUM CYBER NV	$21.11M	N/A	N/A	N/A	N/A	0.68	2.11	N/A	N/A	N/A
AGL	AGILON HEALTH INC	$1.80B	-138.60%	-23.30%	-148.97%	-411.50%	7.30	1.04	-2.50%	-6.10%	-5.95%
AXSM	AXSOME THERAPEUTICS INC	$12.48B	-260.00%	-27.80%	-66.88%	-125.30%	12.07	1.39	92.60%	-26.60%	-25.91%
MOVE	CORVEX INC	$35.72M	-12.70%	-11.70%	-2.55%	-147.40%	0.05	2.14	-190.80%	-2,475.60%	-2,031.07%
QTRX	QUANTERIX CORP	$202.08M	-35.20%	-26.00%	-33.59%	-54.30%	0.30	3.72	44.20%	-71.90%	-73.39%
ANTX	AN2 THERAPEUTICS INC	$158.83M	-52.30%	-47.30%	-42.17%	-89.30%	0.07	15.73	N/A	N/A	N/A
NVCT	NUVECTIS PHARMA INC	$520.70M	-161.00%	-98.90%	-191.00%	238.90%	0.79	2.27	N/A	N/A	N/A
RAPP	RAPPORT THERAPEUTICS INC	$1.84B	-24.80%	-23.40%	-22.36%	-31.20%	0.06	27.08	100.00%	-536.40%	-536.39%
ECOR	ELECTROCORE INC	$68.69M	N/A	-87.70%	-467.09%	-169.10%	-3.72	1.02	87.20%	-44.10%	-42.42%
MAZE	MAZE THERAPEUTICS INC	$1.79B	-36.60%	-31.80%	-30.54%	-78.90%	0.23	17.88	100.00%	-612.70%	-608.38%
DARE	DARE BIOSCIENCE INC	$31.16M	N/A	-46.20%	-179.16%	113.60%	36.89	1.03	53.50%	-1,038.80%	-1,038.77%
ABVX	ABIVAX SA	$11.37B	-98.60%	-69.80%	-44.05%	-1,055.50%	0.27	8.25	100.00%	-6,752.00%	-4,341.95%
CBLL	CERIBELL INC	$750.89M	-38.20%	-30.90%	-36.15%	-35.80%	0.27	10.44	87.70%	-63.50%	-61.56%
ALKS	ALKERMES PLC	$9.19B	8.80%	5.40%	6.48%	16.50%	1.43	2.27	86.60%	9.80%	15.18%
MGTX	MEIRAGTX HOLDINGS PLC	$1.29B	N/A	-55.00%	-158.37%	-83.30%	-5.21	0.55	95.40%	-151.10%	-136.08%
IONS	IONIS PHARMACEUTICALS INC	$12.65B	-58.60%	-10.10%	-8.60%	-6.10%	6.02	4.10	98.40%	-30.90%	-22.21%
IOVA	IOVANCE BIOTHERAPEUTICS INC	$1.87B	-50.20%	-38.80%	-44.55%	-92.90%	0.28	3.61	36.70%	-123.90%	-124.21%
PLYX	POLARYX THERAPEUTICS INC	$125.46M	N/A	N/A	N/A	N/A	0.41	3.45	N/A	N/A	N/A
ACET	ADICET BIO INC	$84.79M	-80.40%	-65.40%	-72.00%	-87.30%	0.21	7.66	N/A	N/A	N/A
BEAM	BEAM THERAPEUTICS INC	$3.63B	-5.90%	-4.60%	-4.63%	-5.60%	0.27	16.99	100.00%	-39.70%	-39.66%
QNCX	QUINCE THERAPEUTICS INC	$13.84M	N/A	-38.10%	-197.19%	-215.70%	0.70	2.92	N/A	N/A	N/A
CTKB	CYTEK BIOSCIENCES INC	$596.64M	-20.80%	-15.60%	-9.90%	-12.30%	0.37	4.69	51.70%	-36.20%	-17.85%
RIGL	RIGEL PHARMACEUTICALS INC	$744.80M	147.00%	99.30%	31.05%	49.00%	0.26	2.62	93.40%	121.50%	42.99%
NTHI	NEONC TECHNOLOGIES HOLDINGS INC	$116.28M	N/A	-1,168.70%	273.68%	323.40%	-1.25	0.13	N/A	N/A	N/A
PROF	PROFOUND MEDICAL CORP	$267.81M	-78.90%	-64.10%	-63.11%	-257.10%	0.24	6.56	71.10%	-206.80%	-210.83%
TLSI	TRISALUS LIFE SCIENCES INC	$264.71M	N/A	-125.50%	-36.38%	-57.00%	4.54	5.78	85.10%	-128.70%	-47.98%
CMPS	COMPASS PATHWAYS PLC	$1.73B	-150.90%	-55.40%	-46.77%	344.50%	0.63	3.32	N/A	N/A	N/A
WVE	WAVE LIFE SCIENCES LTD	$1.22B	-56.80%	-42.80%	-34.40%	931.70%	0.14	11.26	100.00%	-255.70%	-255.70%
SRZN	SURROZEN INC	$274.70M	N/A	-346.50%	-324.35%	-3,450.40%	-1.43	11.91	100.00%	-4,810.50%	-4,810.50%
ACRS	ACLARIS THERAPEUTICS INC	$766.75M	-55.90%	-38.50%	-40.65%	-54.00%	0.38	4.03	9.70%	-832.60%	-832.58%
KIDS	ORTHOPEDIATRICS CORP	$525.26M	-11.40%	-7.90%	-7.17%	-9.20%	0.48	5.21	73.10%	-16.30%	-13.40%
TDOC	TELADOC HEALTH INC	$1.68B	-12.40%	-6.00%	-6.90%	-14.40%	1.10	2.80	69.30%	-6.80%	-6.59%
GRAL	GRAIL INC	$2.96B	-16.40%	-14.30%	-18.90%	-71.50%	0.12	11.74	-36.50%	-253.20%	-330.27%
ACAD	ACADIA PHARMACEUTICALS INC	$4.41B	35.60%	26.20%	8.86%	14.50%	0.29	3.59	91.50%	34.30%	10.51%
DOCS	DOXIMITY INC	$4.18B	19.40%	16.50%	25.81%	31.90%	0.18	6.09	89.10%	30.40%	38.77%
VERU	VERU INC	$45.42M	-52.90%	-37.80%	-37.02%	-395.70%	0.24	6.19	N/A	N/A	N/A
PTHS	PELTHOS THERAPEUTICS INC	$84.56M	-164.10%	-51.20%	-44.65%	-135.60%	3.14	2.79	79.60%	-186.20%	-194.02%
EMBC	EMBECTA CORP	$194.59M	-17.50%	10.30%	34.40%	13.40%	-2.64	2.46	61.90%	10.70%	25.80%
NAMS	NEWAMSTERDAM PHARMA CO NV	$4.08B	-29.80%	-27.40%	-31.98%	-106.30%	0.10	9.76	100.00%	-942.80%	-942.76%
JAGX	JAGUAR HEALTH INC	$1.69M	N/A	-115.60%	1,023.95%	-172.70%	-3.75	0.50	85.10%	-169.50%	-112.61%
DNTH	DIANTHUS THERAPEUTICS INC	$5.10B	-27.30%	-25.90%	-14.37%	-38.00%	0.04	29.25	100.00%	-12,998.50%	-12,998.50%
ALLO	ALLOGENE THERAPEUTICS INC	$721.37M	-56.40%	-40.40%	-46.93%	-49.80%	0.42	9.65	N/A	N/A	N/A
LTRN	LANTERN PHARMA INC	$44.43M	-198.30%	-129.10%	-461.79%	-732.60%	1.10	1.87	N/A	N/A	N/A
RYTM	RHYTHM PHARMACEUTICALS INC	$7.65B	-208.40%	-46.10%	-53.66%	-69.50%	1.67	4.17	89.40%	-95.70%	-83.79%
HYPD	HYPERION DEFI INC	$49.41M	-68.40%	-54.50%	-41.16%	-44.30%	0.20	1.97	70.90%	-3,402.70%	-2,588.52%
LKFT	LAKEFRONT BIOTHERAPEUTICS NV	$2.00B	16.90%	13.90%	14.43%	15.00%	0.04	30.48	97.90%	49.70%	47.97%
BLTE	BELITE BIO INC	$6.06B	-16.90%	-16.60%	-10.07%	-29.10%	0.01	50.02	N/A	N/A	N/A
CORT	CORCEPT THERAPEUTICS INC	$9.83B	7.30%	5.70%	-1.34%	-1.60%	0.28	2.86	98.30%	6.10%	-1.16%
PHAT	PHATHOM PHARMACEUTICALS INC	$907.62M	N/A	-59.70%	-50.79%	-16.70%	-1.91	2.21	84.90%	-76.80%	-44.64%
ALXO	ALX ONCOLOGY HOLDINGS INC	$294.69M	-124.10%	-85.60%	-55.23%	-128.90%	0.18	7.21	N/A	N/A	N/A
MESO	MESOBLAST LTD	$1.85B	-18.20%	-13.10%	-10.17%	-72.20%	0.36	1.58	80.50%	-144.30%	-101.79%
CHRS	COHERUS ONCOLOGY INC	$240.63M	214.60%	50.30%	146.09%	9,214.60%	2.38	1.56	68.10%	397.30%	416.58%
SPTX	SEAPORT THERAPEUTICS INC	$1.04B	N/A	N/A	N/A	N/A	-0.16	13.24	N/A	N/A	N/A
SIGA	SIGA TECHNOLOGIES INC	$268.97M	10.60%	8.90%	17.45%	92.40%	0.45	3.25	65.40%	21.60%	28.69%
ACHV	ACHIEVE LIFE SCIENCES INC	$662.15M	-193.50%	-111.90%	-240.13%	-362.20%	2.10	2.63	N/A	N/A	N/A

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	607	-0.35%	+1.25%	+17.06%	+23.30%	18.36x	5.58x	-117.23%	-12.44%	-9.70%	+53.25%	Strong Buy
Diagnostics & Research	52	-0.02%	+3.31%	+13.74%	+24.32%	12.22x	3.90x	-7.05%	+5.99%	+11.73%	+5.79%	Strong Buy
Drug Manufacturers - General	20	-1.78%	-1.15%	+6.00%	+41.69%	41.49x	7.69x	+34.41%	+12.47%	+22.05%	+5.17%	Buy
Drug Manufacturers - Specialty & Generic	76	-0.55%	+0.67%	+5.56%	-33.67%	-5.96x	1.59x	+7.48%	+4.58%	+50.37%	+33.52%	Strong Buy
Healthcare Plans	10	-1.69%	+1.38%	+4.28%	+24.98%	29.47x	2.54x	+8.80%	+2.75%	+6.81%	-4.37%	Buy
Health Information Services	53	+0.95%	+5.82%	+18.00%	-47.94%	13.03x	3.44x	-8.71%	-0.43%	-0.74%	+17.15%	Buy
Medical Care Facilities	49	-0.40%	+5.21%	+14.56%	-22.16%	16.94x	5.47x	-49.37%	+6.58%	+14.89%	+11.00%	Buy
Medical Devices	135	+0.32%	+2.05%	+7.00%	-99.44%	20.88x	3.11x	+6.02%	+5.31%	+8.92%	+25.36%	Strong Buy
Medical Distribution	10	-0.08%	+4.19%	+6.35%	+10.62%	25.05x	156.87x	-97.12%	+3.72%	+24.95%	+17.15%	Buy
Medical Instruments & Supplies	54	+0.29%	+3.84%	+8.63%	-1.99%	45.23x	3.44x	+5.72%	+6.68%	+10.17%	+19.56%	Strong Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Jul 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Bioventus (NASDAQ:BVS)

Bioventus (NASDAQ:BVS) is the #1 top healthcare stock out of 1066 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Bioventus (NASDAQ:BVS) is: Value: B, Growth: A, Momentum: B, Sentiment: A, Safety: B, Financials: B, and AI: C.

Bioventus (NASDAQ:BVS) has a Due Diligence Score of 44, which is 18 points higher than the healthcare sector average of 26. It passed 14 out of 33 due diligence checks and has strong fundamentals. Bioventus has seen its stock return 72.73% over the past year, overperforming other healthcare stocks by 168 percentage points.

Bioventus has an average 1 year price target of $15.00, an upside of 27.33% from Bioventus's current stock price of $11.78.

Bioventus stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Bioventus, 33.33% have issued a Strong Buy rating, 66.67% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Immucell (NASDAQ:ICCC)

Immucell (NASDAQ:ICCC) is the #2 top healthcare stock out of 1066 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Immucell (NASDAQ:ICCC) is: Value: B, Growth: A, Momentum: B, Sentiment: C, Safety: C, Financials: B, and AI: B.

Immucell (NASDAQ:ICCC) has a Due Diligence Score of 19, which is -7 points lower than the healthcare sector average of 26. Although this number is below the industry average, our proven quant model rates ICCC as a "A".It passed 6 out of 33 due diligence checks and has weak fundamentals. Immucell has seen its stock return 53.94% over the past year, overperforming other healthcare stocks by 149 percentage points.

3. Electromed (NYSEMKT:ELMD)

Electromed (NYSEMKT:ELMD) is the #3 top healthcare stock out of 1066 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Electromed (NYSEMKT:ELMD) is: Value: C, Growth: C, Momentum: B, Sentiment: A, Safety: B, Financials: A, and AI: C.

Electromed (NYSEMKT:ELMD) has a Due Diligence Score of 44, which is 18 points higher than the healthcare sector average of 26. It passed 15 out of 33 due diligence checks and has strong fundamentals. Electromed has seen its stock return 130.17% over the past year, overperforming other healthcare stocks by 225 percentage points.

Electromed has an average 1 year price target of $38.00, a downside of -17.94% from Electromed's current stock price of $46.31.

Electromed stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Electromed, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 74 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 33.28%, which is 31 percentage points higher than the healthcare sector average of 2.65%.

Dominari Holdings's dividend payout ratio of -19.1% indicates that its high dividend yield might not be sustainable for the long-term.

2. Siga Technologies (NASDAQ:SIGA)

Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 16%, which is 13 percentage points higher than the healthcare sector average of 2.65%.

Siga Technologies's dividend payout ratio of 206.9% indicates that its high dividend yield might not be sustainable for the long-term.

3. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) has an annual dividend yield of 14.02%, which is 11 percentage points higher than the healthcare sector average of 2.65%.

Embecta's dividend payout ratio of 31.2% indicates that its high dividend yield is sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -0.32% in the last day, and up 2.16% over the last week. Adapthealth was the among the top losers in the healthcare sector, dropping -4.55% yesterday.

AdaptHealth shares are trading lower after Baird lowered its price target on the stock from $18 to $15.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 43, which is 30 points higher than the healthcare sector average of 13. It passed 3 out of 7 valuation due diligence checks.

Embecta's stock has dropped -67.3% in the past year. It has overperformed other stocks in the healthcare sector by 27 percentage points.

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Ironwood Pharmaceuticals has a valuation score of 86, which is 73 points higher than the healthcare sector average of 13. It passed 6 out of 7 valuation due diligence checks.

Ironwood Pharmaceuticals's stock has gained 514.31% in the past year. It has overperformed other stocks in the healthcare sector by 609 percentage points.

3. Inmode (NASDAQ:INMD)

Inmode (NASDAQ:INMD) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Inmode has a valuation score of 57, which is 44 points higher than the healthcare sector average of 13. It passed 4 out of 7 valuation due diligence checks.

Inmode's stock has dropped -3.31% in the past year. It has overperformed other stocks in the healthcare sector by 91 percentage points.

Are healthcare stocks a good buy now?

61.98% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 27.99% over the next year.

5.22% of healthcare stocks have a Zen Rating of A (Strong Buy), 13.31% of healthcare stocks are rated B (Buy), 48.38% are rated C (Hold), 26% are rated D (Sell), and 7.09% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 29.6x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Bioventus (NASDAQ:BVS)

2. Immucell (NASDAQ:ICCC)

3. Electromed (NYSEMKT:ELMD)

1. Dominari Holdings (NASDAQ:DOMH)

2. Siga Technologies (NASDAQ:SIGA)

3. Embecta (NASDAQ:EMBC)

1. Embecta (NASDAQ:EMBC)

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

3. Inmode (NASDAQ:INMD)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2026)Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Bioventus (NASDAQ:BVS)

2. Immucell (NASDAQ:ICCC)

3. Electromed (NYSEMKT:ELMD)

1. Dominari Holdings (NASDAQ:DOMH)

2. Siga Technologies (NASDAQ:SIGA)

3. Embecta (NASDAQ:EMBC)

1. Embecta (NASDAQ:EMBC)

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

3. Inmode (NASDAQ:INMD)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.